Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07212595
Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy (BRAVE-HEART)
Sponsor: Congenital Heart Alliance of Cincinnati
Conditions
Acute Kidney Injury Mechanical Ventilation
Interventions
Amino Acid infusion Lactated ringers solution
Updated 1 time since 2025 Last updated: Oct 6, 2025 Started: Nov 30, 2025 Primary completion: Nov 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Acute Kidney Injury and Mechanical Ventilation, this trial is actively recruiting participants. The trial is conducted by Congenital Heart Alliance of Cincinnati and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Congenital Heart Alliance of Cincinnati
- Stuart Goldstein, MD
Data source: Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .